The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis

OBJECTIVE: Sarcopenia is characterized by a loss of muscle mass and strength, which leads to frailty and mortality. Rheumatoid arthritis (RA) is considered to be a cause of sarcopenia. The present study assessed the effectiveness of biological disease-modifying antirheumatic drugs (bDMARDs) on sarco...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Eriko, Ito, Satoshi, Kurosawa, Yoichi, Kobayashi, Daisuke, Otani, Hiroshi, Abe, Asami, Nakazono, Kiyoshi, Murasawa, Akira, Narita, Ichiei, Ishikawa, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970816/
https://www.ncbi.nlm.nih.gov/pubmed/36725065
http://dx.doi.org/10.2169/internalmedicine.9600-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970816/
https://www.ncbi.nlm.nih.gov/pubmed/36725065
http://dx.doi.org/10.2169/internalmedicine.9600-22

Ejemplares similares